Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Rades

Showing results (411-420 of 586) with videos related to

Pageof 59
Sort By:
Anticancer Research|January 29, 2018
Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized TrialDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2007
Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobinDirk Rades, Hildegard Kuhn, Juergen Schultze, et al.
Anticancer Research|July 5, 2022
Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck CancerDirk Rades, Britta Warwas, Florian Cremers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compressionDirk Rades, Marisa Lange, Theo Veninga, et al.
Journal of Personalized Medicine|July 29, 2023
A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck CancerDirk Rades, Inga Zwaan, Christian Idel, et al.
Journal of Personalized Medicine|June 28, 2023
First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m<sup>2</sup> Cisplatin for Locally Advanced Head and Neck CancerInga Zwaan, Tamer Soror, Christian Idel, et al.
Frontiers in Immunology|October 19, 2018
<i>Macrophage Migration Inhibitory Factor</i> (MIF) Drives Murine Psoriasiform DermatitisSiegfried Bezdek, Lin Leng, Hauke Busch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2016
Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9bRegina Maushagen, Stefan Reers, Ann-Christin Pfannerstill, et al.
Radiation Oncology (London, England)|February 10, 2018
1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroupsDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
Pageof 59

Showing results (411-420 of 586) with videos related to

Sort By:
Pageof 59
Anticancer Research|January 29, 2018
Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized TrialDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2007
Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobinDirk Rades, Hildegard Kuhn, Juergen Schultze, et al.
Anticancer Research|July 5, 2022
Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck CancerDirk Rades, Britta Warwas, Florian Cremers, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compressionDirk Rades, Marisa Lange, Theo Veninga, et al.
Journal of Personalized Medicine|July 29, 2023
A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck CancerDirk Rades, Inga Zwaan, Christian Idel, et al.
Journal of Personalized Medicine|June 28, 2023
First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m<sup>2</sup> Cisplatin for Locally Advanced Head and Neck CancerInga Zwaan, Tamer Soror, Christian Idel, et al.
Frontiers in Immunology|October 19, 2018
<i>Macrophage Migration Inhibitory Factor</i> (MIF) Drives Murine Psoriasiform DermatitisSiegfried Bezdek, Lin Leng, Hauke Busch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 5, 2007
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancerDirk Rades, Rudolf Schwarz, Manuel Todorovic, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2016
Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9bRegina Maushagen, Stefan Reers, Ann-Christin Pfannerstill, et al.
Radiation Oncology (London, England)|February 10, 2018
1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroupsDirk Rades, Antonio J Conde-Moreno, Jon Cacicedo, et al.
Pageof 59